U.S. Nutraceuticals, LLC v. Cyanotech Corporation

CourtCourt of Appeals for the Eleventh Circuit
DecidedOctober 30, 2014
Docket13-12863
StatusPublished

This text of U.S. Nutraceuticals, LLC v. Cyanotech Corporation (U.S. Nutraceuticals, LLC v. Cyanotech Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eleventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
U.S. Nutraceuticals, LLC v. Cyanotech Corporation, (11th Cir. 2014).

Opinion

Case: 13-12863 Date Filed: 10/30/2014 Page: 1 of 35

[PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT ________________________

No. 13-12863 ________________________

D.C. Docket No. 5:12-cv-00266-WTH-TRL

U.S. NUTRACEUTICALS, LLC, a Florida limited liability corporation, d.b.a. Valensa International,

Plaintiff-Appellee, versus

CYANOTECH CORPORATION, a Nevada corporation,

Defendant-Appellant.

________________________

Appeal from the United States District Court for the Middle District of Florida _______________________

(October 30, 2014)

Before WILSON, WILLIAM PRYOR and ROSENBAUM, Circuit Judges.

WILLIAM PRYOR, Circuit Judge:

We must decide in this appeal whether a district court erred when it denied a

motion to compel arbitration even though the parties expressly stated that the rules Case: 13-12863 Date Filed: 10/30/2014 Page: 2 of 35

of the American Arbitration Association governed their arbitration agreement.

Cyanotech Corporation, a company that develops natural products made with

microalgae, moved to compel arbitration after Valensa, its competitor, sued

Cyanotech for tortious interference with contract and breach of a confidentiality

agreement. Cyanotech argued that Valensa had to arbitrate, not litigate, those

allegations based on arbitration provisions contained in two contracts between the

parties. But the district court denied that motion. Because the parties clearly and

unmistakably incorporated the rules of the Association into their arbitration

provisions, the district court erred when it refused to allow an arbitrator to decide

whether their dispute is arbitrable under one of the parties’ contracts. See Terminix

Int’l Co. v. Palmer Ranch Ltd. P’ship, 432 F.3d 1327, 1332 (11th Cir. 2005). We

reverse and remand for the district court to compel arbitration.

I. BACKGROUND Valensa and Cyanotech entered into two contracts, in which they agreed that

Cyanotech would sell a species of algae called Haematococcus pluvialis to

Valensa. Valensa used that algae to extract an antioxidant compound, astaxanthin,

which is a central ingredient of its nutritional supplements. On November 2, 2007,

the two entered into the first contract, which was effective through November 2,

2010. Then on November 1, 2010, they entered into the second contract, which

was effective through December 31, 2012.

2 Case: 13-12863 Date Filed: 10/30/2014 Page: 3 of 35

Both contracts contained nearly identical confidentiality provisions that

forbade either party from disclosing confidential and proprietary information

without the other party’s consent. But the confidentiality provision in the 2010

contract added an additional provision, which allowed a party to litigate any breach

of the confidentiality agreement:

Each Party to this Agreement recognizes that disclosure of the other Party’s confidential and proprietary information may cause irreparable damage to the non-disclosing Party. Unauthorized disclosure of a Party’s confidential information shall constitute a material breach of this Agreement and is cause for termination of the Agreement by the non-disclosing Party. The non-disclosing Party may seek all remedies available by law, including injunctive relief, and may pursue any such action in a court of competent jurisdiction . . . .

Both contracts also contained arbitration provisions that required the

arbitration of certain disputes under the rules of the Association, but these

arbitration provisions differed in one significant respect. The arbitration provision

in the 2007 contract mandated the arbitration of any dispute that arose under that

contract:

The parties agree to resolve any dispute, controversy or claim that arises hereunder through good faith discussions and written correspondence, each in good faith attempting to understand the other’s position and to resolve the matter amicably. If thereafter, a party at its sole discretion determines that any such dispute cannot thus be resolved, such dispute shall be subject to binding arbitration in Los Angeles, CA under the auspices and rules of the American Arbitration Association by a single arbitrator.

3 Case: 13-12863 Date Filed: 10/30/2014 Page: 4 of 35

But the arbitration provision in the 2010 contract contained a carve-out for any

dispute that related to the breach of confidentiality provision:

The Parties agree to resolve any dispute, controversy or claim that arises hereunder through good faith discussions and written correspondence, each in good faith attempting to understand the other’s position and to resolve the matter amicably. If thereafter, a Party at its sole discretion determines that any such dispute cannot be so resolved, the dispute, other than a dispute relating to breach of the confidentiality provision of this Agreement, shall be subject to final and binding, arbitration by a single arbitrator in the State of Washington under the auspices and rules of the American Arbitration Association. At some point after Cyanotech and Valensa executed the first contract, but

before executing the second, Valensa initiated another lucrative business

relationship with a third company, Mercola. In October 2010, the chief executive

officer of Valensa and a principal of Mercola appeared together in YouTube videos

that discussed nutritional supplements. That same month, Valensa and Mercola

announced a licensing and supply agreement for a health product containing

astaxanthin. Valensa then began supplying Mercola with a different astaxanthin

product containing another ingredient, perilla, in March 2011.

Cyanotech also had dealings with Mercola. In September 2010, the Vice

President of Sales and Marketing at Cyanotech sent an email to Mercola discussing

its microalgae products, including astaxanthin. He offered to supply astaxanthin to

Mercola and sent “a care package with samples and literature” to Mercola.

4 Case: 13-12863 Date Filed: 10/30/2014 Page: 5 of 35

In February 2012, Mercola informed Valensa that it planned to end its

relationship with Valensa and would instead purchase the astaxanthin product

directly from Cyanotech. Mercola explained that Cyanotech offered lower prices,

and Valensa now contends that Cyanotech approached Mercola and offered

Mercola discounted prices if it purchased directly from Cyanotech. Valensa sent a

letter to Cyanotech and requested that Cyanotech cease any business dealings with

Mercola. When Cyanotech failed to do so, Valensa sued Cyanotech in federal

court.

Valensa’s complaint alleged two causes of action against Cyanotech:

tortious interference with its business relationship with Mercola and breach of the

confidentiality agreement in the 2010 contract. The complaint alleged that

Cyanotech interfered with the Valensa-Mercola relationship by coaxing Mercola to

buy directly from Cyanotech after Cyanotech revealed confidential information

that it had learned during its dealings with Valensa. Although the complaint

alleged that Cyanotech and Valensa had a business relationship beginning in 2007,

it referenced only the 2010 contract and not the 2007 contract.

Cyanotech moved to compel arbitration, but the district court denied that

motion. Cyanotech filed a reply brief supporting its motion to compel arbitration,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Gregory v. Electro-Mechanical Corp.
83 F.3d 382 (Eleventh Circuit, 1996)
Elizabeth Bess v. Check Express
294 F.3d 1298 (Eleventh Circuit, 2002)
At&T Technologies, Inc. v. Communications Workers
475 U.S. 643 (Supreme Court, 1986)
First Options of Chicago, Inc. v. Kaplan
514 U.S. 938 (Supreme Court, 1995)
Howsam v. Dean Witter Reynolds, Inc.
537 U.S. 79 (Supreme Court, 2002)
Doe v. Princess Cruise Lines, Ltd.
657 F.3d 1204 (Eleventh Circuit, 2011)
Michael Dasher v. RBC Bank
745 F.3d 1111 (Eleventh Circuit, 2014)
Ivax Corp. v. B. Braun of America, Inc.
286 F.3d 1309 (Eleventh Circuit, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
U.S. Nutraceuticals, LLC v. Cyanotech Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/us-nutraceuticals-llc-v-cyanotech-corporation-ca11-2014.